“The compound SR-17018 is the initial biased agonist in the mu opioid receptor that does not lead to tolerance with Serious use,” says Stahl, a senior staff scientist in the Bohn lab. “This is a fascinating attribute for likely use inside the context of chronic, intense soreness.” HealingEnergy14 stated: https://9royalstreet.com/product/sr-17018-vendor/